Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangjun Kong

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Dermatology|November 10, 2025
Successful treatment of refractory and recurrent pyoderma gangrenosum with pustules and ulcers using spesolimabXinyue Pang, Lisha Tan, Boyu Zhao, et al.
Expert Opinion on Therapeutic Patents|May 7, 2014
Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citationsJiachen Xu, Xiangjun Kong, Lan Qiu, et al.
Protein and Peptide Letters|November 9, 2010
Structure-based prediction of the mobility and disorder of water molecules at protein-DNA interfaceXiaoli Luo, Fenglin Lv, Yuzhu Pan, et al.
Urology|October 4, 2022
Extra-Kidney MassQinwen Liu, Ge Li, Zhihui Yang, et al.
Plos One|March 10, 2025
Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritisYingming Liu, Xiangjun Kong, Qianshu Sun, et al.
Journal of Cosmetic Dermatology|February 9, 2025
Successful Treatment of Complex and Refractory Rosacea Using Platelet-Rich Plasma Injection Therapy: Case Series and Review of the LiteratureXinyue Pang, Lisha Tan, Boyu Zhao, et al.
Cells|January 24, 2025
Plant Coping with Cold Stress: Molecular and Physiological Adaptive Mechanisms with Future PerspectivesYan Feng, Zengqiang Li, Xiangjun Kong, et al.
RSC Advances|November 25, 2022
The development of activated carbon from corncob for CO<sub>2</sub> captureXia Wang, Wulan Zeng, Chunling Xin, et al.
Oncotargets and Therapy|July 7, 2016
Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reportsHaixia Liu, Wei Shi, Lianli Zhao, et al.
Expert Opinion on Therapeutic Patents|September 12, 2017
Global patent landscape of programmed cell death 1: implications of the rapid expansionXiangjun Kong, Qianru Zhang, Yunfeng Lai, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Dermatology|November 10, 2025
Successful treatment of refractory and recurrent pyoderma gangrenosum with pustules and ulcers using spesolimabXinyue Pang, Lisha Tan, Boyu Zhao, et al.
Expert Opinion on Therapeutic Patents|May 7, 2014
Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citationsJiachen Xu, Xiangjun Kong, Lan Qiu, et al.
Protein and Peptide Letters|November 9, 2010
Structure-based prediction of the mobility and disorder of water molecules at protein-DNA interfaceXiaoli Luo, Fenglin Lv, Yuzhu Pan, et al.
Urology|October 4, 2022
Extra-Kidney MassQinwen Liu, Ge Li, Zhihui Yang, et al.
Plos One|March 10, 2025
Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritisYingming Liu, Xiangjun Kong, Qianshu Sun, et al.
Journal of Cosmetic Dermatology|February 9, 2025
Successful Treatment of Complex and Refractory Rosacea Using Platelet-Rich Plasma Injection Therapy: Case Series and Review of the LiteratureXinyue Pang, Lisha Tan, Boyu Zhao, et al.
Cells|January 24, 2025
Plant Coping with Cold Stress: Molecular and Physiological Adaptive Mechanisms with Future PerspectivesYan Feng, Zengqiang Li, Xiangjun Kong, et al.
RSC Advances|November 25, 2022
The development of activated carbon from corncob for CO<sub>2</sub> captureXia Wang, Wulan Zeng, Chunling Xin, et al.
Oncotargets and Therapy|July 7, 2016
Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reportsHaixia Liu, Wei Shi, Lianli Zhao, et al.
Expert Opinion on Therapeutic Patents|September 12, 2017
Global patent landscape of programmed cell death 1: implications of the rapid expansionXiangjun Kong, Qianru Zhang, Yunfeng Lai, et al.
Pageof 11